Bill Text: NY A04141 | 2023-2024 | General Assembly | Introduced

New York Assembly Bill 4141

NOTE: There are more recent revisions of this legislation. Read Latest Draft

Bill Title: Prohibits cost sharing for insulin; provides that an insured shall not be subject to a deductible, copayment, coinsurance or any other cost sharing requirement for the purchase of insulin.

Spectrum: Moderate Partisan Bill (Democrat 47-13)

Status: (Introduced) 2024-01-25 - print number 4141a [A04141 Detail]

Download: New_York-2023-A04141-Introduced.html


                STATE OF NEW YORK
        ________________________________________________________________________

                                          4141

                               2023-2024 Regular Sessions

                   IN ASSEMBLY

                                    February 10, 2023
                                       ___________

        Introduced  by M. of A. FORREST -- read once and referred to the Commit-
          tee on Insurance

        AN ACT to amend the insurance law, in relation to capping  cost  sharing
          for insulin

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subparagraph (B) of paragraph 15-a  of  subsection  (i)  of
     2  section  3216  of the insurance law, as amended by section 1 of part DDD
     3  of chapter 56 of the laws of 2020, is amended to read as follows:
     4    (B) Such coverage may be subject to annual deductibles and coinsurance
     5  as may be deemed appropriate by the superintendent and as are consistent
     6  with those  established  for  other  benefits  within  a  given  policy;
     7  provided however, the total amount that [a covered person] an insured is
     8  required  to  pay  out  of pocket for covered prescription insulin drugs
     9  shall be capped in aggregate, including situations where the insured  is
    10  prescribed  more  than one insulin drug, at an amount not to exceed [one
    11  hundred] thirty dollars per [thirty-day supply] calendar month,  regard-
    12  less  of  the  amount  or  type  of insulin needed to fill such [covered
    13  person's] insured's prescription and regardless of the insured's deduct-
    14  ible, copayment, coinsurance or any other cost sharing requirement.
    15    § 2. Subparagraph (B) of paragraph 7 of subsection (k) of section 3221
    16  of the insurance law, as amended by section 2 of part DDD of chapter  56
    17  of the laws of 2020, is amended to read as follows:
    18    (B) Such coverage may be subject to annual deductibles and coinsurance
    19  as may be deemed appropriate by the superintendent and as are consistent
    20  with  those  established  for  other  benefits  within  a  given policy;
    21  provided however, the total amount that [a covered person] an insured is
    22  required to pay out of pocket for  covered  prescription  insulin  drugs
    23  shall  be capped in aggregate, including situations where the insured is
    24  prescribed more than one insulin drug, at an amount not to  exceed  [one
    25  hundred]  thirty dollars per [thirty-day supply] calendar month, regard-

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02649-02-3

        A. 4141                             2

     1  less of the amount or type of  insulin  needed  to  fill  such  [covered
     2  person's] insured's prescription and regardless of the insured's deduct-
     3  ible, copayment, coinsurance or any other cost sharing requirement.
     4    §  3.  Paragraph  2 of subsection (u) of section 4303 of the insurance
     5  law, as amended by section 3 of part DDD of chapter 56 of  the  laws  of
     6  2020, is amended to read as follows:
     7    (2) Such coverage may be subject to annual deductibles and coinsurance
     8  as may be deemed appropriate by the superintendent and as are consistent
     9  with  those  established  for  other  benefits  within  a  given policy;
    10  provided however, the total amount that [a covered person]  an  enrollee
    11  is  required to pay out of pocket for covered prescription insulin drugs
    12  shall be capped in aggregate, including situations where the enrollee is
    13  prescribed more than one insulin drug, at an amount not to  exceed  [one
    14  hundred]  thirty dollars per [thirty-day supply] calendar month, regard-
    15  less of the amount or type of  insulin  needed  to  fill  such  [covered
    16  person's]  enrollee's  prescription  and  regardless  of the [insured's]
    17  enrollee's deductible, copayment, coinsurance or any other cost  sharing
    18  requirement.
    19    §  4.  This  act  shall take effect immediately and shall apply to any
    20  policy or contract issued, renewed, modified, altered, or amended on  or
    21  after January 1, 2024.